Literature DB >> 1660754

Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem.

N R al-Rodhan1, E Richelson, J A Gilbert, D J McCormick, K S Kanba, M A Pfenning, A Nelson, E W Larson, T L Yaksh.   

Abstract

Neurotensin, an endogenous tridecapeptide, produces a potent, naloxone-insensitive antinociceptive response when it is microinjected into the periaqueductal gray region of the rat brainstem. In the present study, the ED50 for neurotensin in inducing antinociception was 1.5 nmol, two times more potent than morphine. We sought to find whether neurotensin's antinociceptive effects were mediated by the same receptor that mediates its other functions. We found that the structure-activity relationship of neurotensin-induced antinociception was different from that required for the stimulation of intracellular cyclic GMP production in neuroblastoma clone N1E-115 and the binding to N1E-115 cells, human brain tissue, or rat periaqueductal gray. These data suggest there exists a subtype of neurotensin receptors in neural tissue that mediates its antinociceptive actions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660754     DOI: 10.1016/0006-8993(91)90139-m

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.

Authors:  B M Tyler; K Jansen; D J McCormick; C L Douglas; M Boules; J A Stewart; L Zhao; B Lacy; B Cusack; A Fauq; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

Review 3.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

4.  Identification of the receptor subtype involved in the analgesic effect of neurotensin.

Authors:  I Dubuc; P Sarret; C Labbé-Jullié; J M Botto; E Honoré; E Bourdel; J Martinez; J Costentin; J P Vincent; P Kitabgi; J Mazella
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

5.  Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.

Authors:  Pat Bauco; Pierre-Paul Rompré
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

6.  Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Authors:  C Betancur; M Canton; D Gully; G Vela; D Pélaprat; W Rostène
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

7.  Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsy.

Authors:  Hee-Kyoung Lee; Liuyin Zhang; Misty D Smith; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

8.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29

9.  Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.

Authors:  F Oury-Donat; O Thurneyssen; N Gonalons; P Forgez; D Gully; G Le Fur; P Soubrie
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.

Authors:  Geneviève Roussy; Marc-André Dansereau; Stéphanie Baudisson; Faouzi Ezzoubaa; Karine Belleville; Nicolas Beaudet; Jean Martinez; Elliott Richelson; Philippe Sarret
Journal:  Mol Pain       Date:  2009-07-06       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.